(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Addition of a Dedicated Securities Account for Share Repurchase
Filed with SSE · Stock code 603351 · · 1 page · Chinese
Summary by 6ix AI
Nanjing Well Pharmaceutical Group Co. Ltd. announced the addition of a dedicated securities account for share repurchase.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Nanjing Well Pharmaceutical Group Co. Ltd. on 6ix
Story so far
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
- Announcement on Key Operating Data for the First Half of 2026
- Announcement on Share Pledge and Release of Share Pledge by Shareholder Holding More Than 5% of the Shares
Earlier from Nanjing Well Pharmaceutical
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
- Announcement on Key Operating Data for the First Half of 2026
- Announcement on Share Pledge and Release of Share Pledge by Shareholder Holding More Than 5% of the Shares
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Implementation of Dividend Distribution for 2025
Later from Nanjing Well Pharmaceutical
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
Follow Nanjing Well Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Well Pharmaceutical